Human F8/Coagulation factor VI
II Antibody, InVivo Block/Neutralizing Antibody-Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody- 询价
- Biogradetech
- 美国
- BGT-ANT-37334
- 2025年07月13日
- ELISA,Neutralization
- Human
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
免疫原详情见datasheet，该抗体亚型为：IgG4
- 保存条件：
-2°C-8°C
- 保质期：
1年
- 库存：
100
- 供应商：
艾美捷科技
- 宿主：
Human
- 应用范围：
ELISA,Neutralization
- 抗体英文名：
Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody
- 抗体名：
Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody
Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody，Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody，Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody,Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody
产品名称：Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody-Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody
产品货号：BGT-ANT-37334
产品规格：100ug#1mg
应用类型：ELISA,Neutralization
蛋白别名：AHF, Procoagulant component, Coagulation factor VIII, Antihemophilic factor, F8C, F8
Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody-Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody详情见产品datasheet
点击：Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody-Human F8/Coagulation factor VIII Antibody, InVivo Block/Neutralizing Antibody更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Identification of Mutations in the Human Factor VII Gene
It has been recognized from the early 1800s that activation of coagulation can be initiated by the exposure of subendothelial layers (tissue factor), but it was the 1940s before factor VII (FVII) was included in this event
Ex Vivo Stromal Cell Electroporation of Factor IX cDNA for Treatment of Hemophilia B
Hemophilia B is an X-linked genetic disorder that typically results from chronic circulating deficiency of blood coagulation factor IX (FIX) (1). While the occurrence of hemophilia B is significantly less frequent than hemophilia A (factor
secondary antibody review -- data from 99 publications
cytometry used as a control to detect cell responses targeted antigen 7 Alexa Fluor 488 7 Cy3 8 goat IgG Alexa Fluor 488 1:2000 detect antibody binding in human embryonic kidney 293T cells Invitrogen 9 donkey
技术资料暂无技术资料 索取技术资料
